about
Regulation of DNA-dependent protein kinase by protein kinase CK2 in human glioblastoma cellsStructure of the human protein kinase CK2 catalytic subunit CK2α' and interaction thermodynamics with the regulatory subunit CK2βEnzymatic activity with an incomplete catalytic spine: insights from a comparative structural analysis of human CK2α and its paralogous isoform CK2α'UV light blocks EGFR signalling in human cancer cell lines.Resorufin: a lead for a new protein kinase CK2 inhibitor.The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule.Protein kinase CK2 localizes to sites of DNA double-strand break regulating the cellular response to DNA damageDisruption of the regulatory beta subunit of protein kinase CK2 in mice leads to a cell-autonomous defect and early embryonic lethalityEvaluation of somatostatin and nucleolin receptors for therapeutic delivery in non-small cell lung cancer stem cells applying the somatostatin-analog DOTATATE and the nucleolin-targeting aptamer AS1411.Highly Effective Auger-Electron Therapy in an Orthotopic Glioblastoma Xenograft Model using Convection-Enhanced DeliveryStructural basis of the constitutive activity of protein kinase CK2.The Basic Principles of FDG-PET/CT Imaging.Evaluation of cobalt-labeled octreotide analogs for molecular imaging and auger electron-based radionuclide therapy.Role of polyamines in determining the cellular response to chemotherapeutic agents: modulation of protein kinase CK2 expression and activity.Selectivity analysis of protein kinase CK2 inhibitors DMAT, TBB and resorufin in cisplatin-induced stress responses.Exploring the intramolecular phosphorylation sites in human Chk2.Biochemical characterization of CK2alpha and alpha' paralogues and their derived holoenzymes: evidence for the existence of a heterotrimeric CK2alpha'-holoenzyme forming trimeric complexes.Ability of CK2beta to selectively regulate cellular protein kinases.The regulatory beta-subunit of protein kinase CK2 regulates cell-cycle progression at the onset of mitosis.A PSMA Ligand Labeled with Cobalt-55 for PET Imaging of Prostate Cancer.In Vivo Evaluation of a Bombesin Analogue Labeled with Ga-68 and Co-55/57.Dual time-point FDG PET/CT and FDG uptake and related enzymes in lymphadenopathies: preliminary results.Chelation, formulation, encapsulation, retention, and in vivo biodistribution of hydrophobic nanoparticles labelled with Co-porphyrin: Oleylamine ensures stable chelation of cobalt in nanoparticles that accumulate in tumorsNovel radioisotope-based nanomedical approachesEmodin negatively affects the phosphoinositide 3-kinase/AKT signalling pathway: a study on its mechanism of actionLinked Hexokinase and Glucose-6-Phosphatase Activities Reflect Grade of Ovarian Malignancy
P50
Q24296152-5B3BDBAD-111E-45F1-A2BF-4879E3157D94Q27666529-284DC6B6-53C2-4504-9293-C670E4A19D23Q27670730-8ACFA13F-20D5-48AF-ABBB-18531B9DF469Q33265358-7D70CAED-4A4D-45E7-A7B3-C007C617EBB3Q33403729-A1AF71E1-7BF4-4795-A746-0CE306780C01Q33920975-1D12DD63-7B5D-4591-957B-94FE5B95E5B1Q34190250-C90ADD94-93DD-466B-A4F1-EF91F0263B69Q34463459-B938F53A-C24D-4BB6-9B91-3C84F26C2446Q36380909-5471C2FA-9DF5-4374-9CB1-949F2BFBDD71Q37469883-4693648E-A935-4CBE-BA36-EC767E3DDD97Q37805186-5BCF9AD5-E13C-48D6-8A26-8F85D869F3C4Q38518983-3A4E9592-DAD1-48BF-BA49-377466AABB5FQ38990204-4D777EA3-770D-414B-AAC5-0CD4DABEEAD1Q39507693-C9EBECAB-7EDE-41A6-BB7C-546AC24ED402Q39793889-71226AC0-7E95-47B3-91A2-735302C484C0Q39936706-3933187A-FEB3-42FB-99DF-7F7D1A9B73E6Q39968855-8C53A50F-8461-4AAA-A6A6-D9B99BE7897DQ39971416-7C292D50-8363-404E-913F-02D02DC92166Q45744379-9717BB50-BF26-4C82-A335-EB5BC084A9C9Q47963642-B3400C73-EB2C-49C7-90E2-51BB4CC87A40Q48105870-E51B326F-F91F-4F28-BF97-69278A97A0EFQ50661596-657801FE-C97D-4F8A-9368-4BD8C9D73CB5Q57037900-656C3A65-06F7-487E-990C-9D8C852B54EEQ60297975-54C46CF4-B9B8-440F-B64C-F8F4A158264EQ79181299-246CA930-E1DB-4F57-B32C-3B29D4BBBD9CQ89483654-8E1E71DD-A703-4CB9-A94E-D3067266C95B
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Birgitte B Olsen
@ast
Birgitte B Olsen
@en
Birgitte B Olsen
@es
Birgitte B Olsen
@nl
Birgitte B Olsen
@sl
type
label
Birgitte B Olsen
@ast
Birgitte B Olsen
@en
Birgitte B Olsen
@es
Birgitte B Olsen
@nl
Birgitte B Olsen
@sl
prefLabel
Birgitte B Olsen
@ast
Birgitte B Olsen
@en
Birgitte B Olsen
@es
Birgitte B Olsen
@nl
Birgitte B Olsen
@sl
P108
P106
P21
P31
P496
0000-0002-6130-0387